Triamterene and Hydrochlorothiazide
- Product NDC
- 70934-462
- 11-digit product format
- 709340462
- Labeler code
- 70934
- Product ID
- 70934-462_a7ac3823-9817-0ca1-e053-2995a90a0c59
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA071851
- Marketing category
- ANDA
- Marketing start
- 2020-02-04
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 75 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-462-30 | 70934046230 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-462-30) | 30 tablet | 2020-02-04 | 0000-00-00 | No | No | Current |